Paul Sargos
@PaulSargos
Followers
2K
Following
21K
Media
556
Statuses
6K
🇫🇷 Radiation Oncologist 🔆Head of Department, Radiotherapy, Bergonie, Bordeaux 🔅Radiotherapy, Charlebourg-La Defense, Paris 🔆CC-AFU, GETUG, GFRU, ESTRO
Bordeaux, France
Joined October 2018
RT @B_Tomasik: 🚨Happy to share that I'm launching a new study called RAPSTAR - the first randomised, multicentre phase III trial comparing….
0
8
0
RT @DrDarrenPoon: 1st prospective study for MR-guided STAR (Stereotactic Total Ablative RT) for PCa with oligomets 🩻 (5 or less). 🙍🏻♂️N=43….
0
7
0
RT @PBlanchardMD: @GETUG_Unicancer research & teaching days are on! .Two days of discussion, updates and clinical trials development. Led….
0
4
0
🇫🇷🇧🇪Ouverture des JER du @GETUG_Unicancer avec le débat sur la prise en charge des mCRPC. ✨.@RoubaudG.@BertrandTOMBAL.@Helissey4.@alicebernardt
0
5
12
RT @FocusMeeting: Presidents of FOCUS 2025 meets Spain : @Ecastromarcos @kbensalah35 . 🗓 9 & 10 October 2025 .📍Centre de congrès Pierre Bau….
0
3
0
RT @APCCC_Lugano: Active Surveillance for Screen-detected Low- and Intermediate-risk Prostate Cancer: Extended Follow-up up to 25 Years in….
0
27
0
RT @medicalwatchBC: @yekeduz_emre @EAntonarakis @nataliagandur @_ShankarSiva @PaulSargos What are Top Posts of the….
0
3
0
RT @medicalwatchBC: @yekeduz_emre @EAntonarakis @nataliagandur @_ShankarSiva 5/ @PaulSargos on managing gynecomastia with ARPIs monotherapy….
0
2
0
RT @APCCC_Lugano: Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collabor….
0
68
0
RT @Achard_Verane: Honored to be co–first author with @ConstanceHuck on this paper challenging dogma. Next : #BRACEClinicalTrial, which I….
0
3
0
RT @ConstanceHuck: 🚨 MUST READ 🚨.🔥 Bladder preservation with CIS? Time to rethink the rules. 👉 New in EUO: 🙏 Grat….
0
10
0
RT @PaulSargos: ✨ JUST OUT in EUO,. New paper challenging a dogma. ⏩ MUST READ:.@ConstanceHuck has done a great job to show that CIS is no….
0
26
0
✨ JUST OUT in EUO,. New paper challenging a dogma. ⏩ MUST READ:.@ConstanceHuck has done a great job to show that CIS is not always a contra-indication for Trimodal Therapy in the management of MIBC. 🙏Thanks to all co-authors for their input! .
2
26
80
RT @EUplatinum: 🔵 NEW #WoW in European Urology by @DanieleRaggi83 . Does extended lymphadenectomy (eLND) improve outcomes in MIBC?.📉 No DFS….
0
12
0
RT @APCCC_Lugano: Ejaculation Frequency and Risk of #ProstateCancer Updated Results with an Additional Decade of Follow-up. .
0
73
0
RT @_ShankarSiva: 🥳 Today, we randomised the final patient on @TROGfightcancer 19.06 DECREASE trial! This trial randomised patients with….
0
34
0
RT @mirrorsmed: Why attend #RENALC25, #BLADDR25 and #PROSCA25? Hear it straight from @Achard_Verane in this quick video 👇.➡️ Register now:….
0
10
0
How to manage gynecomastia with ARPIs monotherapy?.A review by @nassimVibert 🙏. #ProstateCancer #Prostate #life
0
11
31